Lb Pharmaceuticals INC (LBRX) — S-1/A Filings
All S-1/A filings from Lb Pharmaceuticals INC. Browse 1 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (1)
-
LB Pharma's Schizophrenia Drug Nears Phase 3, Targets $12B Market
— Sep 8, 2025 Risk: high
LB Pharmaceuticals Inc. (LBRX) is a clinical-stage biopharmaceutical company focused on neuropsychiatric diseases, with its lead product candidate, LB-102, a Ph
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX